We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Technology Deciphers Immune Cell Communication to Predict Immunotherapy Response

By LabMedica International staff writers
Posted on 09 Aug 2025

A healthy immune system depends on complex communication between specialized cell types that detect, alert, and eliminate harmful threats. When these immune signaling pathways break down, the result can be autoimmune disorders, uncontrolled infections, or cancer progression. Cancer cells, in particular, can block or manipulate immune communication to evade detection and resist treatment, making it difficult to predict which patients will respond to immunotherapies. Now, a new technology that allows researchers to “listen in” on this immune cell dialogue could help predict who will benefit from immunotherapy.

A research team, led by the Berlin Institute of Health at Charité (Berlin, Germany), Max Delbrück Center (Berlin, Germany), and collaborators, has developed a new technology that decodes how immune cells interact. This innovation allows researchers to "listen in" on immune cell dialogue, measuring millions of cell-to-cell interactions rapidly and cost-effectively. The tool bridges medicine, computer science, and biology.


Image: The new technology could predict who will benefit from immunotherapy (Photo courtesy of Max Delbrück Center)
Image: The new technology could predict who will benefit from immunotherapy (Photo courtesy of Max Delbrück Center)

The researchers tested the technology in multiple disease contexts, including cancer, viral infections, and autoimmune conditions. They used it to study how immunotherapies influence immune cell communication and mapped dynamic immune networks across tissues in high resolution. Their findings, published in Nature Methods, highlight how this method can track immune behavior and its evolution over time.

These insights pave the way for personalized immunotherapies by predicting which patients will benefit most from treatment. The technology also offers a powerful tool to understand immune coordination in diverse diseases. The team is now partnering with clinical institutions to implement the tool in practice and improve patient outcomes by tailoring therapies more precisely.

Related Links:
Berlin Institute of Health at Charité
Max Delbrück Center


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II

Latest Immunology News

AI Model Accurately Predicts MSI Tumor and Immune Checkpoint Inhibitor Responsiveness
09 Aug 2025  |   Immunology

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients
09 Aug 2025  |   Immunology

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes
09 Aug 2025  |   Immunology